PMGC HOLDINGS INC. Operating Expenses
PMGC HOLDINGS INC. (ELAB) reported Operating Expenses of $4.21 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-14
- PMGC HOLDINGS INC. operating expenses for the quarter ending 2026-06-30 was $4.21M, a 315.67% increase year-over-year.
- PMGC HOLDINGS INC. operating expenses for the quarter ending 2026-03-31 was $3.56M, a 196.54% increase year-over-year.
- PMGC HOLDINGS INC. operating expenses for the quarter ending 2025-12-31 was $2.58M, a 53.12% increase year-over-year.
- PMGC HOLDINGS INC. operating expenses for the quarter ending 2025-09-30 was $2.28M, a 263.95% increase year-over-year.
- PMGC HOLDINGS INC. operating expenses for fiscal 2025 was $7.07M, a 92.91% increase from fiscal 2024.
- PMGC HOLDINGS INC. operating expenses for fiscal 2024 was $3.66M, a 221.10% increase from fiscal 2023.
- PMGC HOLDINGS INC. operating expenses for fiscal 2023 was $1.14M, a 49.03% decline from fiscal 2022.
- PMGC HOLDINGS INC. operating expenses for fiscal 2022 was $2.24M.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $4.21M 10-Q · filed 2026-08-14 | $7.78M 10-Q · filed 2026-08-14 | $10.35M derived: sum of 3 quarters · filed 2026-08-14 | $12.63M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | $3.56M 10-Q · filed 2026-05-15 | $6.14M derived: sum of 2 quarters · filed 2026-05-15 | $8.42M derived: sum of 3 quarters · filed 2026-05-15 | $9.43M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | $2.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $4.85M derived: sum of 2 quarters · filed 2026-03-30 | $5.87M derived: sum of 3 quarters · filed 2026-08-14 | $7.07M 10-K · filed 2026-03-30 | ||||
| 2025-09-30 | $2.28M 10-Q · filed 2025-11-14 | $3.29M derived: sum of 2 quarters · filed 2026-08-14 | $4.49M 10-Q · filed 2025-11-14 | $6.17M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | $1.01M 10-Q · filed 2026-08-14 | $2.22M 10-Q · filed 2026-08-14 | $3.90M derived: sum of 3 quarters · filed 2026-08-14 | $4.52M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-03-31 | $1.20M 10-Q · filed 2026-05-15 | $2.88M derived: sum of 2 quarters · filed 2026-05-15 | $3.51M derived: sum of 3 quarters · filed 2026-05-15 | $4.07M derived: sum of 4 quarters · filed 2026-05-15 | ||||
| 2024-12-31 | $1.68M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $2.31M derived: sum of 2 quarters · filed 2026-03-30 | $2.86M derived: sum of 3 quarters · filed 2026-03-30 | $3.66M 10-K · filed 2026-03-30 | ||||
| 2024-09-30 | $625.62K 10-Q · filed 2025-11-14 | $1.31M 10-Q · filed 2024-11-14 | $1.18M derived: sum of 2 quarters · filed 2025-11-14 | $1.98M 10-Q · filed 2025-11-14 | $5.29M 10-Q · filed 2024-11-14 | -$235.36K derived: sum of 4 quarters · filed 2025-11-14 | ||
| 2024-06-30 | $556.24K 10-Q · filed 2025-08-13 | $1.85M 10-Q · filed 2024-08-14 | $1.36M 10-Q · filed 2025-08-13 | $3.98M 10-Q · filed 2024-08-14 | -$860.98K derived: sum of 3 quarters · filed 2025-08-13 | $290.72K derived: sum of 4 quarters · filed 2025-08-13 | ||
| 2024-03-31 | $799.97K 10-Q · filed 2025-05-14 | $2.13M 10-Q · filed 2024-05-15 | -$1.42M derived: sum of 2 quarters · filed 2025-05-14 | -$265.52K derived: sum of 3 quarters · filed 2025-05-14 | $996.16K derived: sum of 4 quarters · filed 2025-05-14 | |||
| 2023-12-31 | -$2.22M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | -$1.07M derived: sum of 2 quarters · filed 2025-03-28 | $196.18K derived: sum of 3 quarters · filed 2025-03-28 | $1.14M 10-K · filed 2025-03-28 | $4.90M 10-K · filed 2024-03-29 | |||
| 2023-09-30 | $1.15M 10-Q · filed 2024-11-14 | $1.15B 10-Q · filed 2023-12-11 | $2.41M derived: sum of 2 quarters · filed 2024-11-14 | $3.36M 10-Q · filed 2024-11-14 | $3.36B 10-Q · filed 2023-12-11 | -$1.47B derived: sum of 4 quarters · filed 2024-11-14 | ||
| 2023-06-30 | $1.26M 10-Q · filed 2024-08-14 | $2.21M 10-Q · filed 2024-08-14 | -$1.47B derived: sum of 3 quarters · filed 2024-08-14 | -$756.84M derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | $944.78K 10-Q · filed 2024-05-15 | -$1.47B derived: sum of 2 quarters · filed 2024-05-15 | -$758.11M derived: sum of 3 quarters · filed 2024-05-15 | |||||
| 2022-12-31 | -$1.47B derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | -$759.05M derived: sum of 2 quarters · filed 2024-03-29 | $2.24M 10-K · filed 2024-03-29 | |||||
| 2022-09-30 | $709.53M 10-Q · filed 2023-12-11 | $1.47B 10-Q · filed 2023-12-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |